Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02019628 · ClinicalTrials.gov registry record · NA
Enhanced Natural Killer Cell Activity and RBAC
A NA study, sponsored by University of Miami.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT02019628 is a NA study that has completed, run by University of Miami. The registered enrollment target is 20 participants.
The verdict
NCT02019628, a NA study, has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The present study investigated the effect of RBAC on natural killer cell activity (NKCA) and the production of cytokines and growth factors over 4 weeks among healthy adults.
Interventions
- DIETARY_SUPPLEMENT Rice Bran Arabinoxylan Compound (RBAC)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2009-11 |
| Est. Completion | 2011-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02019628
The ClinicalTrials.gov registry entry for NCT02019628 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Rice Bran Arabinoxylan Compound (RBAC) is the first listed.
NCT02019628 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02019628 about?
NCT02019628 is a clinical study titled "Enhanced Natural Killer Cell Activity and RBAC". The present study investigated the effect of RBAC on natural killer cell activity (NKCA) and the production of cytokines and growth factors over 4 weeks among healthy adults.
What is the current status of trial NCT02019628?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2009-11. Estimated completion is 2011-11.
What interventions are being tested in trial NCT02019628?
The interventions under investigation include: Rice Bran Arabinoxylan Compound (RBAC) (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02019628?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.